Developing Drug Products in an Aging Society

Developing Drug Products in an Aging Society

This book aims to address the major aspects of future drug product development and therapy for older adults, giving practical guidance for the rational product and clinical development and prescribing of drug products to this ever growing ...

Author: Sven Stegemann

Publisher: Springer

ISBN: 3319430971

Category: Medical

Page: 894

View: 881

This book aims to address the major aspects of future drug product development and therapy for older adults, giving practical guidance for the rational product and clinical development and prescribing of drug products to this ever growing segment of the population. With authors coming from key “aging” markets such as Europe, the USA, China and Japan, the book will provide valuable information for students, scientists, regulators, practitioners, and other healthcare professionals from academia, industry and regulatory bodies.
Categories: Medical

Developing Drug Products in an Aging Society

Developing Drug Products in an Aging Society

Drug. Product. Development. for. Older. Adults—Multiparticulate. Formulations. Norbert Pöllinger Abstract The ... as a highly feasible approach to present convenient and patient friendly medication for the geriatric population.

Author: Sven Stegemann

Publisher: Springer

ISBN: 9783319430997

Category: Medical

Page: 771

View: 620

This book aims to address the major aspects of future drug product development and therapy for older adults, giving practical guidance for the rational product and clinical development and prescribing of drug products to this ever growing segment of the population. With authors coming from key “aging” markets such as Europe, the USA, China and Japan, the book will provide valuable information for students, scientists, regulators, practitioners, and other healthcare professionals from academia, industry and regulatory bodies.
Categories: Medical

Using Technology to Improve Care of Older Adults

Using Technology to Improve Care of Older Adults

State-of-the-art developments in multiple new technologies for older adult care Grounded in a unique team-based geriatrics perspective, this book delivers a broad range of current, evidence-based knowledge about innovative technology that ...

Author: Diane Chau

Publisher: Springer Publishing Company

ISBN: 9780826142436

Category: Social Science

Page: 336

View: 105

State-of-the-art developments in multiple new technologies for older adult care Grounded in a unique team-based geriatrics perspective, this book delivers a broad range of current, evidence-based knowledge about innovative technology that has the potential to advance the care and well being of older adults. It provides key information about the development, selection, and implementation of technology products, and describes research evidence, education-based initiatives, and systems thinking. The book also examines challenges and barriers to implementation, adoption and innovation. From telehealth and assistive technology in the home to simulation and augmented reality in educational settings, the text provides a hands-on, field-tested articulation of how products can aid in the transitional care process, chronic care delivery, and geriatrics/gerontology education. It discusses technology developments in rural areas, home telehealth, wearable technology, personalized medicine, social robots, technology to assist seniors with cognitive impairments, the potential of artificial intelligence to enhance health care of older adults. The text is written to help health care professionals select the appropriate technology for their needs. Key Features: Describes the most current technology resources, evidence, and developments for older adult care Based on a team-centered approach Written by interprofessional health care providers experienced in implementing, developing and adopting technology to assist older adults Includes case studies depicting technology-related successes and failures Addresses the challenges, barriers, and opportunities for transforming aging with technology across transitions of care
Categories: Social Science

Pharmaceutical Formulation

Pharmaceutical Formulation

For the increasing demand for patient-centered drug product design, hard capsules provide the necessary features to overcome swallowing issues (e.g. sprinkle capsules), ... S. Stegemann, in Developing Drug Products in an Aging Society.

Author: Geoffrey D Tovey

Publisher: Royal Society of Chemistry

ISBN: 9781849739412

Category:

Page: 409

View: 237

Formulation is a key step in the drug design process, where the active drug is combined with other substances that maximise the therapeutic potential, safety and stability of the final medicinal product. Modern formulation science deals with biologics as well as small molecules. Regulatory and quality demands, in addition to advances in processing technologies, result in growing challenges as well as possibilities for the field. Pharmaceutical Formulation provides an up to date source of information for all who wish to understand the principles and practice of formulation in the drug industry. The book provides an understanding of the links between formulation theory and the practicalities of processing in a commercial environment, giving researchers the knowledge to produce effective pharmaceutical products that can be approved and manufactured. The first chapters introduce readers to different dosage forms, including oral liquid products, topical products and solid dosage forms such as tablets and capsules. Subsequent chapters cover pharmaceutical coatings, controlled release drug delivery and dosage forms designed specifically for paediatric and geriatric patients. The final chapter provides an introduction to the vital role intellectual property plays in drug development. Covering modern processing methods and recent changes in the regulatory and quality demands of the industry, Pharmaceutical Formulation is an essential, up to date resource for students and researchers working in academia and in the pharmaceutical industry.
Categories:

Falls and Cognition in Older Persons

Falls and Cognition in Older Persons

Use frequent human communication as a reminder system to improve medication adherence [18]. Conclusions Demographics will drive ... Developing drug products in an aging society from concept to prescribing. New York: Springer; 2016. p.

Author: Manuel Montero-Odasso

Publisher: Springer Nature

ISBN: 9783030242336

Category: Medical

Page: 436

View: 175

Despite of the enormous efforts of researchers and clinicians to understand the pathophysiology of falls in older adults and establish preventive treatments, there is still a significant gap in our understanding and treating of this challenging syndrome, particularly when we focus in cognitively impaired older adults. Falls in older adults are a very common yet complex medical event, being the fifth leading cause of death and a main cause of insidious disability and nursing home placement in our world aging population. Importantly, falls in the cognitively impaired double the prevalence of the cognitively normal, affecting up of 60% of older adults with low cognition and increasing the risk of injuries. The past decade has witnessed an explosion of new knowledge in the role of cognitive processes into the falls mechanisms. This was also accompanied with clinical trials assessing the effect of improving cognition via pharmacological and non-pharmacologic approaches to prevent falls and related injuries. Unfortunately, this revolution in emerging interventions left a gap between clinician-scientists and researchers at academic centers where the new data had been generated and the practitioners who care for cognitively impaired patients with falls. Most advances are published in specialty journals of geriatric medicine, neurology, and rehabilitation. The aim of this book is to reduce this gap and to provide practical tools for fall prevention in cognitively impaired populations. The proposed book is designed to present a comprehensive and state-of the-art update that covers the pathophysiology, epidemiology, and clinical presentation of falls in cognitively impaired older adults. We additionally aim to reduce the knowledge gap in the association between cognitive processes and falls for practitioners from a translational perspective: from research evidence to clinical approach. We will address gaps and areas of uncertainty but also we will provide practical evidence-based guidelines for the assessment, approach, and treatment of falls in the cognitively impaired populations. This book is a unique contribution to the field. Existing textbooks on fall prevention focus in global approaches and only tangentially address the cognitive component of falls and not purposely address special populations and/or settings as residential care and nursing homes. Due to the expected increase of proportion of older adults with cognitive and mobility impairments, this book is also valuable for the whole spectrum of the health care of the elderly. By including a transdisciplinary perspective from geriatric medicine, rehabilitation and physiotherapy medicine, cognitive neurology, and public health, this book will provide a practical and useful resource with wide applicability in falls assessment and prevention.
Categories: Medical

Implications of the Ageing Population on the Pharmaceutical and the Tourism Industry from a Marketing Point of View

Implications of the Ageing Population on the Pharmaceutical and the Tourism Industry from a Marketing Point of View

Essay from the year 2007 in the subject Business economics - Marketing, Corporate Communication, CRM, Market Research, Social Media, grade: 84% - A, University of Sunderland, course: Marketing Strategy, language: English, abstract: Due to ...

Author: Miriam Mennen

Publisher: GRIN Verlag

ISBN: 9783640570218

Category:

Page: 21

View: 671

Essay from the year 2007 in the subject Business economics - Marketing, Corporate Communication, CRM, Market Research, Social Media, grade: 84% - A, University of Sunderland, course: Marketing Strategy, language: English, abstract: Due to the world's demographic development towards an increasing aging population, various richer economies experience major changes influencing the specific industries. This report will illustrate the implications of these changes, with particular reference to the population over the age of 65, on the pharmaceutical and the tourism industry from a marketing point of view. Examples will be drawn from the US, the UK, Germany and Japan as they are highly affected by the changing demographics. The main purpose of the report is among others to outline significant impacts on the micro and macro environment, relating to the mentioned industries. Furthermore, the implications on the particular marketing strategies will be evaluated in order to solve potential problems with their implementation. Finally, recommendations will be given on how to overcome these problems and difficulties.
Categories:

Handbook of Lung Targeted Drug Delivery Systems

Handbook of Lung Targeted Drug Delivery Systems

Bose S. Parenteral Drug Delivery for Older Patients. In: Stegemann S. (ed.) Developing Drug Products in an Aging Society: From Concept to Prescribing. Springer International Publishing, Cham. 2016; 291–329. 62. Waitt C, Waitt M, ...

Author: Yashwant Pathak

Publisher: CRC Press

ISBN: 9781000450767

Category: Medical

Page: 692

View: 920

Handbook of Lung Targeted Drug Delivery Systems: Recent Trends and Clinical Evidences covers every aspect of the drug delivery to lungs, the physiology and pharmacology of the lung, modelling for lung delivery, drug devices focused on lung treatment, regulatory requirements, and recent trends in clinical applications. With the advent of nano sciences and significant development in the nano particulate drug delivery systems there has been a renewed interest in the lung as an absorption surface for various drugs. The emergence of the COVID-19 virus has brought lung and lung delivery systems into focus, this book covers new developments and research used to address the prevention and treatment of respiratory diseases. Written by well-known scientists with years of experience in the field this timely handbook is an excellent reference book for the scientists and industry professionals. Key Features: Focuses particularly on the chemistry, clinical pharmacology, and biological developments in this field of research. Presents comprehensive information on emerging nanotechnology applications in diagnosing and treating pulmonary diseases Explores drug devices focused on lung treatment, regulatory requirements, and recent trends in clinical applications Examines specific formulations targeted to pulmonary systems
Categories: Medical

Microfluidics for Pharmaceutical Applications

Microfluidics for Pharmaceutical Applications

[119] J.F. Schlender, et al., The Personalization of Drug Therapy for Elderly Patients. in Developing Drug Products in an Aging Society, Springer, 2016, pp. 589–611. [120] Veebot, No, Available from: ...

Author: Helder A. Santos

Publisher: William Andrew

ISBN: 9780128126608

Category: Science

Page: 495

View: 921

Microfluidics for Pharmaceutical Applications: From Nano/Micro Systems Fabrication to Controlled Drug Delivery is a concept-orientated reference that features case studies on utilizing microfluidics for drug delivery applications. It is a valuable learning reference on microfluidics for drug delivery applications and assists practitioners developing novel drug delivery platforms using microfluidics. It explores advances in microfluidics for drug delivery applications from different perspectives, covering device fabrication, fluid dynamics, cutting-edge microfluidic technology in the global drug delivery industry, lab-on-chip nano/micro fabrication and drug encapsulation, cell encapsulation and delivery, and cell- drug interaction screening. These microfluidic platforms have revolutionized the drug delivery field, but also show great potential for industrial applications. Presents detailed coverage on the fabrication of novel drug delivery systems with desired characteristics, such as uniform size, Janus particles, and particular or combined responsiveness Includes a variety of case studies that explain principles Focuses on commercialization, cost, safety, society and educational issues of microfluidic applications, showing how microfluidics is used in the real world
Categories: Science

Research Development of the European Pharmaceutical Industry

Research   Development of the European Pharmaceutical Industry

In this paper the structure of the Research & Development sector of the European pharmaceutical industry will be examined, which is of increasing importance for the success of the individual companies.

Author: Arne Noack

Publisher: GRIN Verlag

ISBN: 9783638726702

Category:

Page: 52

View: 139

Seminar paper from the year 2003 in the subject Business economics - Operations Research, grade: A, Vrije University Brussel (Vesalius College), course: Economics, language: English, abstract: The health of their population has always been a great concern for governments of Post-War Europe. In order to achieve their goals they had to work closely together with the pharmaceutical Industry. With the phenomenon of the aging population the importance of development of new drugs is increasing. The increasingly old population of Europe creates a big market for pharmaceutical companies. The pharmaceutical Industry is a very complex sector with close links to other Industries. The chemical Industry for example is an important supplier for materials needed in the process of creating new drugs. Furthermore is the market for pharmaceuticals characterized by extremely little concentration and a huge variety of products. Globally in 1998, the 300 best-selling products held a share of less than 45% of the worlds market. The top two products held 1.3% of the market each.1 This fact creates a necessity for the companies to research new, so called "Blockbuster drugs" to succeed on this market with a high competition. The data on the various methods of drug discovery is enormous and sophisticated. In this paper the structure of the Research & Development sector of the European pharmaceutical industry will be examined, which is of increasing importance for the success of the individual companies. The specific data on the R & D section will be given a general character. Furthermore it will give a brief overview of the different regions in Europe and their individual differences. In the end, the difficulties and challenges of R & D in the pharmaceutical industry will be described and compared to other pharma markets abroad. [1 Data taken from Combining discovery with development" by Dr. Peter Eddershaw; World pharmaceutical frontiers 2003/2004 ]
Categories:

Foundations of Artificial Intelligence in Healthcare and Bioscience

Foundations of Artificial Intelligence in Healthcare and Bioscience

[216] Stegemann S. Developing drug products in an aging society: from concept to prescribing. Cham: Springer; 2016. [217] Schreier G, Schwarz M, Modre-Osprian R, Kastner P, Scherr D, Fruhwald F. Design and evaluation of a multimodal ...

Author: Louis J. Catania

Publisher: Academic Press

ISBN: 9780323860055

Category: Science

Page: 558

View: 162

Foundational Handbook of Artificial Intelligence in Healthcare and Bioscience: A User Friendly Guide for IT Professionals, Healthcare Providers, Researchers, and Clinicians uses color-coded illustrations to explain AI from its basics to modern technologies. Other sections cover extensive, current literature research and citations regarding AI’s role in the business and clinical aspects of health care. The book provides readers with a unique opportunity to appreciate AI technology in practical terms, understand its applications, and realize its profound influence on the clinical and business aspects of health care. Artificial Intelligence is a disruptive technology that is having a profound and growing influence on the business of health care as well as medical diagnosis, treatment, research and clinical delivery. The AI relationships in health care are complex, but understandable, especially when discussed and developed from their foundational elements through to their practical applications in health care. Provides an illustrated, foundational guide and comprehensive descriptions of what Artificial Intelligence is and how it functions Integrates a comprehensive discussion of AI applications in the business of health care Presents in-depth clinical and AI-related discussions on diagnostic medicine, therapeutic medicine, and prevalent disease categories with an emphasis on immunology and genetics, the two categories most influenced by AI Includes comprehensive coverage of a variety of AI treatment applications, including medical/pharmaceutical care, nursing care, stem cell therapies, robotics, and 10 common disease categories with AI applications
Categories: Science